Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, Glentis S, Bournakis E, Bobos M, Pectasides D, Papakostas P, Pentheroudakis G, Gogas H, Skarlos P, Samantas E, Bafaloukos D, Kosmidis PA, Koutras A, Yannoukakos D, Konstantopoulou I, Fountzilas G. Fostira F, et al. Among authors: papadimitriou c. Breast Cancer Res Treat. 2012 Jul;134(1):353-62. doi: 10.1007/s10549-012-2021-9. Epub 2012 Mar 21. Breast Cancer Res Treat. 2012. PMID: 22434525
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Dimopoulos MA, Papadopoulou M, Andreopoulou E, Papadimitriou C, Pavlidis N, Aravantinos G, Aspropotamitis A, Anagnostopoulos A, Fountzilas G, Michalas S, Pectacides D. Dimopoulos MA, et al. Among authors: papadimitriou c. Gynecol Oncol. 1998 Jul;70(1):70-4. doi: 10.1006/gyno.1998.5047. Gynecol Oncol. 1998. PMID: 9698477
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Dimopoulos AM, Papadimitriou C, Kalogera-Fountzila A, Aravantinos G, Bafaloukos D, Athanassiades A, Nicolaides C, Keramopoulos A, Pavlidis N, Kosmidis P, Skarlos D. Fountzilas G, et al. Among authors: papadimitriou c. Ann Oncol. 1998 Sep;9(9):1031-4. doi: 10.1023/A:1008466928323. Ann Oncol. 1998. PMID: 9818080 Free article. Clinical Trial.
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Stathopoulos G, Nicolaides C, Kalogera-Fountzila A, Kalofonos H, Nikolaou A, Bacoyiannis C, Samantas E, Papadimitriou C, Kosmidis P, Daniilidis J, Pavlidis N. Fountzilas G, et al. Among authors: papadimitriou c. Ann Oncol. 1999 Apr;10(4):475-8. doi: 10.1023/a:1008397424359. Ann Oncol. 1999. PMID: 10370793 Free article. Clinical Trial.
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Dimopoulos MA, Bakoyannis C, Georgoulias V, Papadimitriou C, Moulopoulos LA, Deliveliotis C, Karayannis A, Varkarakis I, Aravantinos G, Zervas A, Pantazopoulos D, Fountzilas G, Bamias A, Kyriakakis Z, Anagnostopoulos A, Giannopoulos A, Kosmidis P. Dimopoulos MA, et al. Among authors: papadimitriou c. Ann Oncol. 1999 Nov;10(11):1385-8. doi: 10.1023/a:1008379500436. Ann Oncol. 1999. PMID: 10631471 Free article. Clinical Trial.
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Kosmidis P, Mylonakis N, Skarlos D, Samantas E, Dimopoulos M, Papadimitriou C, Kalophonos C, Pavlidis N, Nikolaidis C, Papaconstantinou C, Fountzilas G. Kosmidis P, et al. Among authors: papadimitriou c. Ann Oncol. 2000 Jul;11(7):799-805. doi: 10.1023/a:1008389402580. Ann Oncol. 2000. PMID: 10997806 Free article. Clinical Trial.
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Papadimitriou C, Dafni U, Bafaloukos D, Skarlos D, Moulopoulos LA, Razis E, Kalofonos HP, Aravantinos G, Briassoulis E, Papakostas P, Abela K, Gogas E, Kosmidis P, Pavlidis N, Dimopoulos MA. Fountzilas G, et al. Among authors: papadimitriou c. J Clin Oncol. 2001 Apr 15;19(8):2232-9. doi: 10.1200/JCO.2001.19.8.2232. J Clin Oncol. 2001. PMID: 11304776 Clinical Trial.
484 results